• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型子宫内膜增生的治疗等待时间审核。

Audit of waiting time-to-treatment of atypical endometrial hyperplasia.

机构信息

Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

Department of Women's Health, Counties Manukau District Health Board, Auckland, New Zealand.

出版信息

Aust N Z J Obstet Gynaecol. 2022 Oct;62(5):707-713. doi: 10.1111/ajo.13551. Epub 2022 Jun 22.

DOI:10.1111/ajo.13551
PMID:35730741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9796385/
Abstract

BACKGROUND

Atypical endometrial hyperplasia (AEH) is the precursor lesion in endometrial carcinoma, the most common gynaecological malignancy in New Zealand, with inequities in disease burden and outcome for Māori and Pacific women.

AIMS

In women diagnosed with AEH at two hospitals, to audit five standards of care for surgical management and time-to-treatment, and identify variation in care by ethnicity and other factors.

MATERIALS AND METHODS

Demographic, referral, diagnostic and treatment characteristics were collected for women with a new AEH diagnosis between 1/1/2019 and 31/12/2020. Surgical management and time-to-treatment were audited against Royal College of Obstetricians and Gynaecologists and New Zealand Ministry of Health Faster Cancer Treatment recommendations.

RESULTS

Of 124 participants, 60% were Pacific, 86% premenopausal, and 80% had obesity. For 55 women managed surgically, surgical standards of care were met. There were delays between referral, diagnosis and treatment - only 18% and 56% of women met the 62-day (referral to treatment) and 31-day (decision-to-treat to treatment) targets, respectively. Wait times were prolonged for women who had dilation and curettage (vs pipelle), magnetic resonance imaging (MRI) (vs no MRI), and surgery (vs medical management). Ethnic disparities were not identified for any standard.

DISCUSSION

Delays to treatment were found throughout women's journeys. Hospital services can streamline their clinical pathways for women referred for abnormal uterine bleeding, flagging obesity as a high suspicion for cancer indicator, increasing access to endometrial sampling in primary care and establishing 'one-stop-shop' outpatient assessment with empiric initiation of intrauterine progestogen.

摘要

背景

非典型子宫内膜增生(AEH)是子宫内膜癌的癌前病变,这是新西兰最常见的妇科恶性肿瘤,毛利人和太平洋岛裔妇女的疾病负担和预后存在不平等现象。

目的

在两家医院诊断为 AEH 的女性中,对手术管理和治疗时间的五项护理标准进行审核,并确定按种族和其他因素划分的护理差异。

材料和方法

收集了 2019 年 1 月 1 日至 2020 年 12 月 31 日期间新诊断为 AEH 的女性的人口统计学、转诊、诊断和治疗特征。根据皇家妇产科医师学院和新西兰卫生部的更快癌症治疗建议,对手术管理和治疗时间进行审核。

结果

在 124 名参与者中,60%是太平洋岛民,86%是绝经前,80%是肥胖。在接受手术治疗的 55 名女性中,有 55 名符合手术护理标准。从转诊到治疗的时间存在延迟,只有 18%和 56%的女性分别达到了 62 天(转诊到治疗)和 31 天(决定治疗到治疗)的目标。行刮宫术(与 pipelle 相比)、磁共振成像(MRI)(与无 MRI 相比)和手术(与药物治疗相比)的女性等待时间延长。任何标准都没有发现种族差异。

讨论

在女性的就诊过程中都发现了治疗延迟。医院服务可以为因异常子宫出血就诊的女性简化临床路径,将肥胖标记为癌症的高可疑指标,增加初级保健中子宫内膜取样的机会,并建立“一站式”门诊评估,同时进行经验性宫内孕激素治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a1/9796385/d99b05292d0a/AJO-62-707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a1/9796385/a13ce05fd94e/AJO-62-707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a1/9796385/8733236de1e1/AJO-62-707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a1/9796385/d99b05292d0a/AJO-62-707-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a1/9796385/a13ce05fd94e/AJO-62-707-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a1/9796385/8733236de1e1/AJO-62-707-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9a1/9796385/d99b05292d0a/AJO-62-707-g003.jpg

相似文献

1
Audit of waiting time-to-treatment of atypical endometrial hyperplasia.非典型子宫内膜增生的治疗等待时间审核。
Aust N Z J Obstet Gynaecol. 2022 Oct;62(5):707-713. doi: 10.1111/ajo.13551. Epub 2022 Jun 22.
2
Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.子宫内膜增生的诊断和管理:2012-2020 年英国国家审计对遵循国家指南的情况
PLoS Med. 2024 Feb 29;21(2):e1004346. doi: 10.1371/journal.pmed.1004346. eCollection 2024 Feb.
3
Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.体重指数在决定是否进行子宫内膜活检方面比年龄更具影响力:有症状的绝经前女性队列研究
Am J Obstet Gynecol. 2016 Nov;215(5):598.e1-598.e8. doi: 10.1016/j.ajog.2016.06.006. Epub 2016 Jun 8.
4
Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.活检诊断为非典型子宫内膜增生的女性并发子宫内膜癌:一项妇科肿瘤学组的研究。
Cancer. 2006 Feb 15;106(4):812-9. doi: 10.1002/cncr.21650.
5
Hysteroscopic inspection and total curettage are insufficient for discriminating endometrial cancer from atypical endometrial hyperplasia.宫腔镜检查和全面刮宫术不足以区分子宫内膜癌和非典型子宫内膜增生。
Tohoku J Exp Med. 2012 Dec;228(4):365-70. doi: 10.1620/tjem.228.365.
6
Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.子宫切除术后并发非典型子宫内膜增生的子宫内膜癌。
Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):80-3. doi: 10.1016/j.ejogrb.2010.02.002. Epub 2010 Feb 24.
7
Retrospective analysis on timeframes of referral, diagnosis and treatment of patients with endometrial carcinomas in Dunedin Hospital, 2008-2011.2008 - 2011年达尼丁医院子宫内膜癌患者转诊、诊断及治疗时间框架的回顾性分析。
N Z Med J. 2013 Oct 18;126(1384):84-95.
8
Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.对有生育潜力的年轻女性早期子宫内膜癌和复杂性不典型增生进行保留生育功能的治疗。
Int J Gynecol Cancer. 2015 Jul;25(6):1010-4. doi: 10.1097/IGC.0000000000000467.
9
Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.术前诊断为非典型子宫内膜增生患者的子宫内膜癌
Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):107-11. doi: 10.1016/j.ejogrb.2005.01.001.
10
Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia.术前诊断为非典型子宫内膜增生的女性并发子宫内膜癌的意义。
J Obstet Gynaecol Can. 2008 Oct;30(10):896-901. doi: 10.1016/S1701-2163(16)32969-3.

本文引用的文献

1
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial.左炔诺孕酮宫内节育系统治疗临床 I 期子宫内膜腺癌的完全病理缓解:一项随机临床试验结果。
Gynecol Oncol. 2021 Apr;161(1):143-151. doi: 10.1016/j.ygyno.2021.01.029.
2
Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.左炔诺孕酮宫内节育系统治疗子宫内膜增生
Cochrane Database Syst Rev. 2020 Sep 6;9(9):CD012658. doi: 10.1002/14651858.CD012658.pub2.
3
Increasing incidence of endometrial carcinoma in a high-risk New Zealand community.
新西兰一个高危社区子宫内膜癌发病率不断上升。
Aust N Z J Obstet Gynaecol. 2020 Apr;60(2):250-257. doi: 10.1111/ajo.13108. Epub 2020 Jan 5.
4
Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.体重指数在决定是否进行子宫内膜活检方面比年龄更具影响力:有症状的绝经前女性队列研究
Am J Obstet Gynecol. 2016 Nov;215(5):598.e1-598.e8. doi: 10.1016/j.ajog.2016.06.006. Epub 2016 Jun 8.
5
Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review.绝经前妇女肥胖与子宫内膜增生和癌症:系统评价。
Am J Obstet Gynecol. 2016 Jun;214(6):689.e1-689.e17. doi: 10.1016/j.ajog.2016.01.175. Epub 2016 Jan 30.
6
Therapeutic options for management of endometrial hyperplasia.子宫内膜增生的治疗选择。
J Gynecol Oncol. 2016 Jan;27(1):e8. doi: 10.3802/jgo.2016.27.e8. Epub 2015 Dec 1.
7
Prediction of regression and relapse of endometrial hyperplasia with conservative therapy.保守治疗子宫内膜增生的消退和复发预测。
Obstet Gynecol. 2013 Jun;121(6):1165-1171. doi: 10.1097/AOG.0b013e31828cb563.
8
Which is the best technique for endometrial sampling? Aspiration (pipelle) versus dilatation and curettage (D&C).哪种子宫内膜取样技术最好?抽吸(pipelle)与扩张和刮宫(D&C)。
Arch Gynecol Obstet. 2012 Nov;286(5):1277-82. doi: 10.1007/s00404-012-2438-8. Epub 2012 Jul 6.
9
Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.孕激素治疗的绝经前妇女中,复杂性非典型增生或 1 级子宫内膜腺癌消退的预测因素。
Gynecol Oncol. 2012 Mar;124(3):542-8. doi: 10.1016/j.ygyno.2011.11.004. Epub 2011 Nov 10.
10
Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.活检诊断为非典型子宫内膜增生的女性并发子宫内膜癌:一项妇科肿瘤学组的研究。
Cancer. 2006 Feb 15;106(4):812-9. doi: 10.1002/cncr.21650.